352 filings
Page 4 of 18
10-Q
2023 Q1
BXRX
Baudax Bio, Inc.
Quarterly report
11 May 23
5:23pm
8-K
BXRX
Baudax Bio, Inc.
10 May 23
Regulation FD Disclosure
8:01am
ARS
2022 FY
BXRX
Baudax Bio, Inc.
28 Apr 23
Annual report to shareholders
4:31pm
DEF 14A
BXRX
Baudax Bio, Inc.
Definitive proxy
28 Apr 23
4:21pm
8-K
BXRX
Baudax Bio, Inc.
28 Apr 23
Entry into a Material Definitive Agreement
4:06pm
424B3
BXRX
Baudax Bio, Inc.
28 Apr 23
Prospectus supplement
4:02pm
EFFECT
BXRX
Baudax Bio, Inc.
27 Apr 23
Notice of effectiveness
12:15am
S-1/A
BXRX
Baudax Bio, Inc.
IPO registration (amended)
26 Apr 23
6:10am
CORRESP
BXRX
Baudax Bio, Inc.
26 Apr 23
Correspondence with SEC
12:00am
CORRESP
BXRX
Baudax Bio, Inc.
26 Apr 23
Correspondence with SEC
12:00am
CORRESP
BXRX
Baudax Bio, Inc.
26 Apr 23
Correspondence with SEC
12:00am
8-K
BXRX
Baudax Bio, Inc.
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
UPLOAD
BXRX
Baudax Bio, Inc.
13 Apr 23
Letter from SEC
12:00am
S-1
BXRX
Baudax Bio, Inc.
IPO registration
6 Apr 23
4:12pm
8-K/A
BXRX
Baudax Bio, Inc.
4 Apr 23
Entry into a Material Definitive Agreement
4:09pm
8-K
BXRX
Baudax Bio, Inc.
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm
8-K
BXRX
Baudax Bio, Inc.
27 Mar 23
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
4:05pm
8-K
BXRX
Baudax Bio, Inc.
13 Mar 23
Regulation FD Disclosure
7:31am
8-K
BXRX
Baudax Bio, Inc.
3 Mar 23
Other Events
8:00am
S-8
BXRX
Baudax Bio, Inc.
23 Feb 23
Registration of securities for employees
8:49am